External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

PAGE Meeting 2025

-
Coming soon
12:30 PM
Duration 90mins Thessaloniki, Greece
A novel mechanistic viral dynamics modeling (MVDM) framework to characterize the effect of combination therapies in chronic hepatitis B and evaluate the influence of individual characteristics in the Piranga phase 2 platform study
Annabelle Lemenuel-Diot, Selma El Messaoudi, Jérémie Guedj, Sylvie Retout, Franziska Schaedeli Stark, Amine Ait-Ali, Nelson Guerreiro, Sijie Lu, Farouk Chughlay, Claire McGeown, Rémi Kazma

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
12:00 PM
Duration 105mins Thessaloniki, Greece
Confirming pharmacokinetic properties of satralizumab▼ using a bodyweight tiered dosing regimen in LUMINESCE, a phase 3 study for generalized Myasthenia Gravis
Hanna Silber Baumann, Sebastien Jolivet, Ekaterina Gibiansky, Jean-Christophe Genin, Jill Smith, Hajime Ito, Sin Lennon-Chrimes

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar